Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
Clinical trial NCT03934216 · COMPLETED
Trial details
- NCT number
- NCT03934216
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2021-06-13
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.